Log In
BCIQ
Print this Print this
 

conjugated liposomal doxorubicin

  Manage Alerts
Collapse Summary General Information
Company NanoSmart Pharmaceuticals Inc.
DescriptionAntinuclear antibody (ANA) conjugated liposomal doxorubicin
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationSarcoma
Indication DetailsTreat Ewing's sarcoma
Regulatory Designation U.S. - Orphan Drug (Treat Ewing's sarcoma)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today